Liver transplantation is associated with a great risk of bleeding, which is
of both surgical and medical etiopathogenesis. All phases of the transplan
tation are characterized by a complicated and continuously evolving derange
ment of pro- and anticoagulant factors, which result in coagulopathy. The m
agnitude of this coagulopathy varies between patients and therefore must be
corrected on an individual basis. During the different phases of the trans
plantation, treatment must be targeted with the aim of controlling the blee
ding according to its pathogenesis. This paper analyzes the problems associ
ated with the monitoring and correction of coagulation during the different
phases of liver transplantation, with specific focus on the idiosyncrasies
of segmental liver transplantation. Blood Coagul Fibrinolysis 11 (suppl 1)
:S81-S85 (C) 2000 Lippincott Williams & Wilkins.